Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Multicenter, prospective and observational study of practices and impacts of the use of antihypertensive therapies in intensive medicine and intensive care
Multicenter, prospective observational cohort study on 200 patients, by doctor's questionnaire on the prescription of antihypertensive drugs in intensive care, follow-up over 72 hours of the prescription.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Inventory of prescribing habits and detect any differences in efficacy and tolerance of antihypertensive drugs | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| Make an inventory of prescribing habits and detect any differences in efficacy and tolerance of antihypertensive drugs in intensive care and intensive care settings | Description in number of drugs | 60 days after inclusion |
| Make an inventory of prescribing habits and detect any differences in efficacy and tolerance of antihypertensive drugs in intensive care and intensive care settings | Description in percentage of drugs | 60 days after inclusion |
| Make an inventory of prescribing habits and detect any differences in efficacy and tolerance of antihypertensive drugs in intensive care and intensive care settings | therapeutic classes | 60 days after inclusion |
| Make an inventory of prescribing habits and detect any differences in efficacy and tolerance of antihypertensive drugs in intensive care and intensive care settings | administration methods | 60 days after inclusion |
| Make an inventory of prescribing habits and detect any differences in efficacy and tolerance of antihypertensive drugs in intensive care and intensive care settings | prescription chronology | 60 days after inclusion |
| Make an inventory of prescribing habits and detect any differences in efficacy and tolerance of antihypertensive drugs in intensive care and intensive care settings | reasons for prescribers | 60 days after inclusion |
| Measure | Description | Time Frame |
|---|---|---|
| Search for efficiency differences between the different molecules | Time to control blood pressure values in the targeted targets | 60 days after inclusion |
| Search for efficiency differences between the different molecules |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
adult patients hospitalized in intensive care
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| GAUDRY Stephane | Contact | 01 48 96 44 55 | stephane.gaudry@aphp.fr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Intensive Care Victor Dupouy Hospital | Recruiting | Argenteuil | 95100 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Need for administration of another antihypertensive drug
| 60 days after inclusion |
| Search for efficiency differences between the different molecules | Disappearance of organ failure attributable to hypertension | 60 days after inclusion |
| Search for efficiency differences between the different molecules | Weaning from an extra-renal purification | 60 days after inclusion |
| Search for efficiency differences between the different molecules | Weaning from mechanical ventilation | 60 days after inclusion |
| Search for efficiency differences between the different molecules | Improved kidney function | 60 days after inclusion |
| Search for differences in side effects between the different molecules | Iatrogenic hypotension | 60 days after inclusion |
| Search for differences in side effects between the different molecules | Need for suspension of treatment | 60 days after inclusion |
| Search for differences in side effects between the different molecules | Other side effect | 60 days after inclusion |
| Intensive Care Avicenne Hsopital | Recruiting | Bobigny | 93000 | France |
|
| Intensive Care Louis Mourier Hospital | Recruiting | Colombes | 92700 | France |
|
| Intensive Care Longjumeau Hospital | Recruiting | Longjumeau | 91160 | France |
|
| Intensive Care Bichat Hospital | Recruiting | Paris | 75018 | France |
|
| Intensive Care René Dubos Hospital | Recruiting | Pontoise | 95300 | France |
|
| Intensive Care Tours Hospital | Recruiting | Tours | 37000 | France |
|